Geneva NetworkJanuary 21, 2021Read OnlineAt every step of the COVID-19 crisis, critics of intellectual property rights (IPRs) have called for their suspension, claiming IPRs will thwart research and development and makes vaccines and treatments unaffordable. Trade and Intellectual Property